Activation of NOD1 on tumor-associated macrophages augments CD8+T cell–mediated antitumor immunity in hepatocellular carcinoma

T cells. These findings unveil a previously unrecognized role for NOD1 in fortifying antitumor T cell immunity in HCC, potentially advancing cancer immunotherapy.